Gut bacteria booster shows promise for IBD relief
NCT ID NCT07318753
First seen Jan 11, 2026 · Last updated May 21, 2026 · Updated 21 times
Summary
This study tests a probiotic called LR607 in 300 people with mild-to-moderate ulcerative colitis, a type of inflammatory bowel disease. The probiotic is designed to boost a natural gut enzyme that helps control inflammation. The goal is to see if adding LR607 to standard treatment can improve symptoms and reduce disease activity.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLAMMATORY BOWEL DISEASE (IBD) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Shenzhen Hospital of Southern Medical University
Shenzhen, Guangdong, 518000, China
Conditions
Explore the condition pages connected to this study.